Approval & Beyond: Risk Assessment in Selecting a Clinical Trial Outcome
Time: 2:00 pm
day: Day Two
Details:
- Review primary outcomes selected for existing examples of cannabinoid drug development: what worked, what didn’t, and why.
- Strengths and weaknesses in choosing patient-reported outcomes, clinician-reported outcomes, and objective outcomes.
- Agency guidance for specific therapeutic areas and agency partnership
